1990-2024年全球及区域HIV-1分子流行病学:系统综述、全球调查与流行率分析
全球分布总体稳定,但区域动态变化需持续监测。
要点
- 各区域变异分布不同:南亚以C为主,东非以A为主,北美与欧洲以B为主。
- 中非HIV-1多样性最高,2000-24年全球分布总体稳定但区域有变化。
核心结论
- 全球及区域HIV-1遗传多样性复杂且持续演变,影响诊断、病毒载量检测、耐药发生和疫苗研发。
- 持续监测HIV-1遗传多样性的时空趋势至关重要。
研究设计与样本
- 系统综述检索PubMed、Embase、Global Health和CINAHL(2022-01-01至2025-01-22)并联合全球调查收集2016-2024年未发表数据。
- 纳入≥20份样本、国家与采样年份已知的1990-2024年原始HIV-1亚型数据,排除无或不完整亚型数据、仅限特定变异、重叠感染或二次数据。
- 数据与1990-2021年已收集数据合并,按国家聚合为六个时期(1990-99、2000-04、2005-09、2010-14、2015-19、2020-24)。
- 按国家和时期计算亚型、循环重组型(CRFs)和独特重组型(URFs)比例,并使用UNAIDS各国HIV感染者数估计进行加权。
- 系统综述注册于PROSPERO,CRD42017067164。
主要发现
- HIV-1变异区域分布不同:南部非洲、埃塞俄比亚、厄立特里亚、吉布提和南亚以C亚型为主;东非、东欧和中亚以A亚型为主;北美、拉丁美洲、西欧和中欧以B亚型为主;东南亚以CRF01_AE为主;东亚以CRF07_BC为主;中非多样性最高。
临床怎么用
- 临床应了解本区域流行HIV-1变异,以辅助选择诊断与病毒载量检测方法并解释结果。
- 对重组型增多区域需关注治疗失败与耐药监测,疫苗开发应覆盖多样变异。
- 持续开展HIV-1分子流行病学监测,为诊断、治疗和预防策略提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The extensive genetic diversity of HIV presents major challenges to treatment and prevention. We aimed to estimate the global and regional distribution of HIV-1 subtypes and recombinants during 1990-2024. METHODS: We conducted a systematic literature review by searching PubMed, Embase, Global Health, and CINAHL for country-specific HIV-1 subtyping data published between Jan 1, 2022, and Jan 22, 2025, and a global survey of the Global HIV Molecular Epidemiology Collaboration for unpublished data collected between 2016 and 2024. We included primary HIV-1 subtyping data with ≥20 samples and known country and years of sample collection during 1990-2024. We excluded publications and survey responses that had no or incomplete subtyping data, were restricted to specific HIV-1 variants, included superinfections, or used secondary data. These data were combined with HIV-1 subtyping data previously collected between 1990 and 2021. Data were aggregated by country for six time periods (1990-99, 2000-04, 2005-09, 2010-14, 2015-19, and 2020-24). Proportions of HIV-1 subtypes, circulating recombinant forms (CRFs), and unique recombinant forms (URFs) were calculated by country and period and were weighted using UNAIDS country estimates of numbers of people living with HIV to estimate regional and global HIV-1 variant proportions. The systematic review is registered with PROSPERO, CRD42017067164. FINDINGS: HIV-1 subtyping data were available for 1 395 222 samples from 154 countries during 1990-2024. In 2020-24, subtype C accounted for 48·7% (95% CI 48·3-49·1) of global HIV-1 infections, followed by subtype A (11·5%; 10·9-12·1), subtype B (10·3%; 10·0-10·5) URFs (5·3%; 4·4-6·3), CRF02_AG (5·1%; 4·5-5·8), CRF01_AE (5·1%; 4·8-5·4), other CRFs (3·9%; 3·3-4·5), subtype G (3·1%; 2·1-4·1), subtype D (3·0%; 2·7-3·3), and CRF07_BC (2·1%; 2·0-2·1). Subtypes F, H, J, K, and L combined accounted for 1·1% of infections and unspecified recombinants for 0·9% (0·7-1·0). HIV-1 variants are differentially distributed across regions, with subtype C dominating in southern Africa; Ethiopia, Eritrea, and Djibouti; and south Asia; subtype A in east Africa and eastern Europe and central Asia; subtype B in North America, Latin America, and western and central Europe; CRF01_AE in southeast Asia; and CRF07_BC in east Asia. Central Africa exhibited the greatest HIV-1 diversity. Global HIV-1 variant distributions were broadly stable during 2000-24, but notable regional changes included increases of HIV-1 recombinants in western and central Europe and of CRF07_BC in east Asia. INTERPRETATION: Global and regional HIV-1 genetic diversity is complex and evolving, affecting the efficacy of diagnostic and viral load assays, emergence of drug resistance, and vaccine development. Continued surveillance of spatiotemporal trends in HIV-1 genetic diversity is essential. FUNDING: Nuffield Department of Population Health, University of Oxford, UK.
引用
- Khalid A, Gettins L, Scullion L, et al. Global and regional molecular epidemiology of HIV-1 during 1990-2024: systematic review, global survey, and analysis of prevalence. Lancet Infect Dis. 2026. PMID: 42155508. doi:10.1016/S1473-3099(26)00142-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。